Approaches to target tractability assessment – a practical perspective (original) (raw)

Author affiliations

* Corresponding authors

a Computational and Modelling Sciences, Platform Technology and Sciences, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania 19426, USA

b NCE Molecular Discovery, Platform Technology and Sciences, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, UK
E-mail: mike.m.hann@gsk.com

c In vitro/In vivo Translation Sciences, Platform Technology and Sciences, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania 19426, USA

d Target Sciences Computational Biology, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, UK

e Computational and Modelling Sciences, Platform Technology and Sciences, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, UK

Abstract

The assessment of the suitability of novel targets to intervention by different modalities, e.g. small molecules or antibodies, is increasingly seen as important in helping to select the most progressable targets at the outset of a drug discovery project. This perspective considers differing aspects of tractability and how it can be assessed using in silico and experimental approaches. We also share some of our experiences in using these approaches.

Graphical abstract: Approaches to target tractability assessment – a practical perspective

You have access to this article

Please wait while we load your content... Something went wrong. Try again?

Article information

DOI

https://doi.org/10.1039/C7MD00633K

Article type

Review Article

Submitted

15 Dec 2017

Accepted

13 Feb 2018

First published

14 Feb 2018

Download Citation

Med. Chem. Commun., 2018,9, 606-613

Permissions

Approaches to target tractability assessment – a practical perspective

K. K. Brown, M. M. Hann, A. S. Lakdawala, R. Santos, P. J. Thomas and K. Todd,Med. Chem. Commun., 2018, 9, 606DOI: 10.1039/C7MD00633K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements